Are we ready for intercultural cancer care?

被引:5
|
作者
Crombez, Patrick [1 ]
Michiels, Sandra [1 ,2 ,3 ]
Bron, Dominique [1 ]
机构
[1] Jules Bordet Inst, Dept Hematol Oncol, Brussels, Belgium
[2] Brussels Free Univ ULB, Ctr Res Epidemiol Biostat & Clin Res, Brussels, Belgium
[3] Brussels Free Univ ULB, Sch Publ Hlth, Ctr Res Social Approaches Hlth, Brussels, Belgium
关键词
adherence; cancer clinical trial enrollment; culture; migrants and ethnic minorities; patient-centered care; CHRONIC MYELOID-LEUKEMIA; CLINICAL-TRIALS; HEMATOLOGICAL CANCER; PARTICIPATION; ADHERENCE; COMMUNICATION; HEALTH; DISPARITIES; ENROLLMENT; BARRIERS;
D O I
10.1097/CCO.0000000000000449
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose of review Migration is increasing worldwide, with accumulating evidence of health disparities. At the same time, oncology faces new challenges within a fast-changing care landscape. These two developments raise the question of integration of migrants and ethnic minorities (MEMs) and cultural influences in oncology. Recent findings Perceptions of health and disease differ substantially across and within societies and cultures. However, health needs of MEMs and cultural influences seem often out of the scope of cancer care. The purpose of this thematic review is to consider three major challenges of current and future oncology through the prism of culture and ethnicity: enrollment in cancer clinical trials, therapeutic adherence, and new models and paradigms of care. We found inconsistent literature highlighting gaps in knowledge, research, and clinical practice. This confirms unequal situations for MEMs in cancer and asserts interactions between culture influences and therapeutic transactions. Summary To eliminate the burden of health disparities and ensure the best outcomes in MEM's cancer patients, a collaborative approach from research and clinical practice is necessary. Only robust research from all countries exploring unmet needs of MEMs and striving for functional understanding can inform and innovate clinical practice.
引用
收藏
页码:205 / 211
页数:7
相关论文
共 50 条
  • [41] Liver transplantation in metastatic colorectal cancer: are we ready for it?
    Javier Ros
    Francesc Salva
    Cristina Dopazo
    Daniel López
    Nadia Saoudi
    Iosune Baraibar
    Ramon Charco
    Josep Tabernero
    Elena Elez
    British Journal of Cancer, 2023, 128 : 1797 - 1806
  • [42] Proteomics in cancer research: Are we ready for clinical practice?
    Maes, Evelyne
    Mertens, Inge
    Valkenborg, Dirk
    Pauwels, Patrick
    Rolfo, Christian
    Baggerman, Geert
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 96 (03) : 437 - 448
  • [43] Personalized lung cancer screening: Are we ready to ENGAGE?
    Gould, Michael K.
    CANCER, 2021, 127 (23) : 4362 - 4364
  • [44] Are we ready for artificial intelligence health monitoring in elder care?
    Ho, Anita
    BMC GERIATRICS, 2020, 20 (01)
  • [45] Immunotherapy for Cervical Cancer: Are We Ready for Prime Time?
    Turinetto, Margherita
    Valsecchi, Anna A.
    Tuninetti, Valentina
    Scotto, Giulia
    Borella, Fulvio
    Valabrega, Giorgio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
  • [46] Are we ready for artificial intelligence health monitoring in elder care?
    Anita Ho
    BMC Geriatrics, 20
  • [48] TESTING FOR HEREDITARY BREAST-CANCER - ARE WE READY
    WARNER, E
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1994, 150 (11) : 1875 - &
  • [49] SBIRT in Emergency Care Settings: Are We Ready to Take it to Scale?
    Bernstein, Edward
    Bernstein, Judith A.
    Stein, Jack B.
    Saitz, Richard
    ACADEMIC EMERGENCY MEDICINE, 2009, 16 (11) : 1072 - 1077
  • [50] Influenza in long-term care: How ready are we?
    Fowler, CN
    Galicia-Castillo, M
    Fahringer, R
    Wieckowska, Z
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2006, 54 (04) : S60 - S60